(Q38192021)

30 August 2017

1 reference

title

Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine (English)

1 reference

30 August 2017

0 references

Shih-Min Wang

1

1 reference

30 August 2017

Ching-Chuan Liu

series ordinal

2

1 reference

30 August 2017

language of work or name

1 reference

3 March 2014

1 reference

Expert Review of Anti-infective Therapy

30 August 2017

published in

1 reference

30 August 2017

volume

12

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

447-456

1 reference

An apparently new enterovirus isolated from patients with disease of the central nervous system

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Enterovirus 71: epidemiology, pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Virology, epidemiology, pathogenesis, and control of enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Clinical features, diagnosis, and management of enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Long-term cognitive and motor deficits after enterovirus 71 brainstem encephalitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Antigenic and genetic diversity of human enterovirus 71 from 2009 to 2012, Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Molecular epidemiology of enterovirus 71 infection in the central region of Taiwan from 2002 to 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Enterovirus 71 outbreak, Brunei

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Clinical and virological features of enterovirus 71 infections in Denmark, 2005 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Enterovirus 71 infection with central nervous system involvement, South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Emergence and transmission pathways of rapidly evolving evolutionary branch C4a strains of human enterovirus 71 in the Central Plain of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Genetic and antigenic characterization of enterovirus 71 in Ho Chi Minh City, Vietnam, 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Patterns of polymorphism and divergence in the VP1 gene of enterovirus 71 circulating in the Asia-Pacific region between 1994 and 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Epidemiology of human enterovirus 71 infections in France, 2000-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

The association between enterovirus 71 infections and meteorological parameters in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Perspectives on the basic reproductive ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Estimation of the basic reproduction number of enterovirus 71 and coxsackievirus A16 in hand, foot, and mouth disease outbreaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Risk factors for hand, foot, and mouth disease and herpangina and the preventive effect of hand-washing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Virus entry: molecular mechanisms and biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Scavenger receptor B2 is a cellular receptor for enterovirus 71

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

A murine oral enterovirus 71 infection model with central nervous system involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1β, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Enterovirus 71 infection increases expression of interferon-gamma-inducible protein 10 which protects mice by reducing viral burden in multiple tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Increased frequency of Th17 cells in the peripheral blood of children infected with enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Association of interleukin 10 and interferon gamma gene polymorphisms with enterovirus 71 encephalitis in patients with hand, foot and mouth disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Excessive proinflammatory cytokine and chemokine responses of human monocyte-derived macrophages to enterovirus 71 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Proteomic analysis of extremely severe hand, foot and mouth disease infected by enterovirus 71

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Enterovirus 71 infection of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Pathogenesis study of enterovirus 71 infection in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Exogenous interleukin-6, interleukin-13, and interferon-γ provoke pulmonary abnormality with mild edema in enterovirus 71-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Transgenic mouse model for the study of enterovirus 71 neuropathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Adaptation of enterovirus 71 to adult interferon deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Implications of Age-Dependent Immune Responses to Enterovirus 71 Infection for Disease Pathogenesis and Vaccine Design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Enterovirus 71 Infection of Monocytes with Antibody-Dependent Enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

EV71: an emerging infectious disease vaccine target in the Far East?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Development of enterovirus 71 vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Reactogenicity and immunogenicity of an enterovirus 71 vaccine in Chinese healthy children and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: a phase II, Randomized, double-blind, placebo-controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

Significant elevation of B cells at the acute stage in enterovirus 71-infected children with central nervous system involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.895666

10.1586/14787210.2014.895666

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference